Last reviewed · How we verify
NCT03341455
Family Violence and Alcohol and Drug Misuse in Sri Lanka
NA trial testing Capacity building to support families affected by IPV & substance misuse in Intimate Partner Violence in 900 participants. Completed in 28 February 2019.
30 December 2018
Quick facts
| Lead sponsor | Australian National University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 900 |
| Start date | 23 January 2018 |
| Primary completion | 30 December 2018 |
| Estimated completion | 28 February 2019 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Capacity building to support families affected by IPV & substance misuse
Conditions studied
- Intimate Partner Violence — all drugs for Intimate Partner Violence →
- Domestic Abuse — all drugs for Domestic Abuse →
- Drug and Alcohol Abuse — all drugs for Drug and Alcohol Abuse →
Sponsor
Australian National University
Who can join
18 and older, any sex, with Intimate Partner Violence or Domestic Abuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to implement a community-based support program delivered by preschool teachers and volunteer parents that will increase awareness, knowledge and uptake of available services for IPV and substance misuse, and of the link between these issues and poorer education outcomes in children. Through this, the aim is to decrease the prevalence of IPV and substance misuse. The proposed method of implementation is to deliver targeted training to preschool teachers, mothers with children at the preschools, fathers with children at the preschools, and community development officers managing preschools. This project will target the most vulnerable sections of the community and will provide a sustainable and feasible strategy for scale up of the intervention. By intervening through these preschools the investigators aim to identify and support high-risk families early enough to arrest the cycle of violence that results in children themselves becoming victims and perpetrators of such violence.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Primary-level and community worker interventions for the prevention of mental disorders and the promotion of well-being in low- and middle-income countries.
Purgato M, Prina E, Ceccarelli C, Cadorin C, et al · · 2023 · cited 17× · PMID 37873968 · DOI 10.1002/14651858.cd014722.pub2 -
Protocol for a cluster-randomised controlled trial evaluating the impact of a preschool-based capacity building intervention on intimate partner violence and substance misuse in Sri Lanka.
Lokuge K, Wallace P, Subasinghe K, Thurber K, et al · · 2018 · cited 1× · PMID 29716553 · DOI 10.1186/s12889-018-5423-8
Verify or expand the search:
- PubMed search for NCT03341455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intimate Partner Violence
Currently open trials in the same condition.
- NCT07226401 — Virtual Village for Young Parents · NA · recruiting
- NCT06988787 — Multifaceted Intervention to Restore Resilience and Overcome Risk · NA · recruiting
- NCT05106361 — MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intim · NA · active not recruiting
- NCT06074068 — Father-Focused Intervention for Reducing Family Violence and Symptoms in Children · NA · recruiting
- NCT06071299 — Impact of Family-Centered Care for Intimate Partner Violence (IPV) · NA · active not recruiting
Other Australian National University trials
Trials by the same sponsor.
- NCT04545541 — Nebulised Heparin in Patients With Severe COVID-19 · Phase 2, PHASE3 · completed
- NCT04635241 — Inhaled Heparin for Hospitalised COVID-19 Patients · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03341455 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Australian National University
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing